Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Larry Allen

Concepts (627)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
275
2026
2329
28.770
Why?
Heart-Assist Devices
64
2024
572
11.940
Why?
Stroke Volume
55
2025
652
5.530
Why?
Atrial Fibrillation
39
2024
560
4.570
Why?
Decision Making
26
2024
993
3.980
Why?
Patient Readmission
28
2024
778
3.860
Why?
Heart Transplantation
19
2026
682
3.250
Why?
Decision Support Techniques
16
2022
478
3.190
Why?
Registries
53
2025
2400
3.120
Why?
Quality of Life
49
2025
3200
3.030
Why?
Ventricular Dysfunction, Left
15
2023
391
3.000
Why?
Guideline Adherence
17
2026
594
2.760
Why?
Health Expenditures
8
2025
198
2.710
Why?
Cardiology
21
2025
363
2.630
Why?
Palliative Care
24
2025
1032
2.590
Why?
Humans
376
2026
146342
2.490
Why?
Ventricular Function, Left
20
2024
541
2.480
Why?
Patient Participation
17
2026
457
2.450
Why?
Drug Costs
6
2025
116
2.440
Why?
Caregivers
22
2026
1080
2.300
Why?
Aged
164
2026
26432
2.210
Why?
Hospitalization
50
2026
2475
2.090
Why?
Cardiovascular Agents
6
2025
165
2.000
Why?
United States
122
2026
16136
1.980
Why?
Hospice Care
9
2021
230
1.970
Why?
Patient Discharge
29
2026
997
1.940
Why?
Ambulatory Care
11
2025
628
1.900
Why?
Defibrillators, Implantable
15
2022
393
1.860
Why?
Practice Patterns, Physicians'
14
2026
1408
1.780
Why?
Practice Guidelines as Topic
18
2026
1591
1.770
Why?
Anticoagulants
18
2024
746
1.710
Why?
Middle Aged
132
2026
36619
1.660
Why?
American Heart Association
20
2025
364
1.660
Why?
Male
189
2026
73396
1.650
Why?
Terminal Care
10
2025
284
1.620
Why?
Medicare
32
2024
920
1.620
Why?
Female
195
2026
79499
1.600
Why?
Risk Assessment
35
2026
3712
1.590
Why?
Aged, 80 and over
72
2026
8391
1.580
Why?
Cardiotonic Agents
10
2021
96
1.540
Why?
Outpatients
10
2023
440
1.430
Why?
Stroke
16
2024
1287
1.420
Why?
Treatment Outcome
61
2026
11821
1.410
Why?
Patient Preference
6
2018
226
1.390
Why?
Angiotensin Receptor Antagonists
14
2025
115
1.370
Why?
Health Status
14
2023
827
1.280
Why?
Cardiovascular Diseases
18
2026
2219
1.250
Why?
Myocardial Infarction
9
2023
1215
1.240
Why?
Angiotensin-Converting Enzyme Inhibitors
11
2025
228
1.240
Why?
Patient-Centered Care
12
2024
553
1.220
Why?
Quality Improvement
11
2026
1354
1.200
Why?
Adrenergic beta-Antagonists
10
2025
253
1.200
Why?
Withholding Treatment
5
2019
77
1.160
Why?
Delivery of Health Care
11
2023
947
1.150
Why?
Randomized Controlled Trials as Topic
12
2025
1763
1.150
Why?
Heart Ventricles
6
2021
762
1.140
Why?
Medication Adherence
8
2026
535
1.120
Why?
Aminobutyrates
7
2023
31
1.120
Why?
Cardiomyopathies
7
2026
340
1.120
Why?
Prognosis
31
2024
4351
1.110
Why?
Inpatients
5
2023
540
1.100
Why?
Hemorrhage
11
2024
825
1.100
Why?
Aftercare
17
2023
225
1.090
Why?
Family
4
2023
690
1.050
Why?
Hospitals
10
2024
738
1.040
Why?
Risk Factors
50
2026
10921
1.040
Why?
Biphenyl Compounds
8
2023
67
1.010
Why?
Health Knowledge, Attitudes, Practice
10
2025
1408
1.010
Why?
Valsartan
6
2022
33
0.970
Why?
Patient Care Management
3
2017
54
0.970
Why?
Cost of Illness
7
2025
323
0.970
Why?
Cardiovascular System
6
2024
137
0.970
Why?
Health Care Costs
8
2024
423
0.960
Why?
Consumer Health Information
3
2017
44
0.940
Why?
Mineralocorticoid Receptor Antagonists
8
2025
69
0.900
Why?
Surveys and Questionnaires
23
2024
6073
0.900
Why?
Clinical Decision-Making
9
2024
365
0.880
Why?
Heart Failure, Systolic
3
2018
26
0.860
Why?
Acute Coronary Syndrome
2
2023
299
0.840
Why?
Death, Sudden, Cardiac
5
2025
242
0.840
Why?
Quality Indicators, Health Care
9
2026
343
0.830
Why?
Patient Selection
10
2019
728
0.830
Why?
Internet
4
2020
660
0.820
Why?
Patient Reported Outcome Measures
11
2024
516
0.800
Why?
Angiotensin II Type 1 Receptor Blockers
2
2020
39
0.800
Why?
Symporters
1
2024
49
0.800
Why?
Anti-Arrhythmia Agents
4
2020
144
0.800
Why?
Biomedical Research
3
2020
729
0.790
Why?
Survival Analysis
14
2019
1378
0.780
Why?
Protease Inhibitors
2
2020
103
0.770
Why?
Patient Education as Topic
4
2018
770
0.770
Why?
Follow-Up Studies
27
2024
5439
0.760
Why?
Cannabis
3
2024
521
0.760
Why?
Quality of Health Care
8
2024
702
0.760
Why?
Text Messaging
5
2026
188
0.750
Why?
Heart Injuries
1
2023
41
0.740
Why?
Physicians
7
2023
955
0.720
Why?
Global Health
2
2025
403
0.710
Why?
Spirituality
1
2023
88
0.710
Why?
Diuretics
4
2023
66
0.700
Why?
Telemedicine
8
2026
966
0.680
Why?
Device Removal
2
2020
149
0.660
Why?
Informed Consent
3
2023
195
0.650
Why?
Amyloid Neuropathies, Familial
3
2026
26
0.650
Why?
Transitional Care
3
2021
46
0.640
Why?
Catheter Ablation
4
2020
355
0.640
Why?
Percutaneous Coronary Intervention
2
2023
550
0.640
Why?
Retrospective Studies
44
2026
17438
0.630
Why?
Biomarkers
8
2024
4340
0.630
Why?
Patient Care Team
5
2024
701
0.620
Why?
Insurance, Health
3
2017
318
0.620
Why?
Health Policy
3
2021
399
0.610
Why?
Population Health
1
2020
44
0.600
Why?
Adult
56
2026
41087
0.600
Why?
Healthcare Disparities
10
2025
733
0.600
Why?
Societies, Medical
6
2024
907
0.600
Why?
Attitude to Death
4
2023
74
0.590
Why?
Propanolamines
1
2019
40
0.590
Why?
Time Factors
24
2026
7109
0.590
Why?
Patient Rights
1
2019
11
0.590
Why?
Cause of Death
8
2020
456
0.570
Why?
Length of Stay
7
2018
1358
0.570
Why?
Diabetes Mellitus, Type 2
6
2026
2623
0.570
Why?
Drug Substitution
2
2018
62
0.570
Why?
Quality Assurance, Health Care
3
2015
349
0.550
Why?
Myocarditis
3
2026
103
0.550
Why?
Medicaid
4
2021
477
0.550
Why?
Pneumonia, Viral
2
2020
387
0.550
Why?
Coronavirus Infections
2
2020
379
0.540
Why?
Health Status Indicators
3
2020
167
0.540
Why?
Hospices
5
2021
95
0.540
Why?
Manuscripts, Medical as Topic
1
2017
5
0.530
Why?
Interviews as Topic
10
2025
930
0.530
Why?
Attitude to Health
4
2019
421
0.530
Why?
Heart Diseases
2
2014
343
0.520
Why?
Cocaine
1
2019
162
0.520
Why?
Peer Review
1
2017
47
0.520
Why?
Peer Review, Research
1
2017
36
0.520
Why?
Advance Care Planning
3
2025
244
0.510
Why?
Warfarin
7
2022
179
0.510
Why?
Qualitative Research
15
2026
1734
0.500
Why?
Editorial Policies
1
2017
46
0.500
Why?
Disease Management
7
2025
651
0.490
Why?
Disease Progression
15
2025
2867
0.490
Why?
Insurance Claim Review
2
2014
87
0.490
Why?
Physician-Patient Relations
3
2020
597
0.490
Why?
Heart Valve Prosthesis Implantation
2
2021
197
0.490
Why?
Angina, Unstable
3
2006
83
0.480
Why?
Patient Acceptance of Health Care
6
2026
881
0.480
Why?
Stress, Psychological
3
2021
1171
0.480
Why?
Health Plan Implementation
1
2017
143
0.480
Why?
Survival Rate
11
2026
2092
0.470
Why?
Comorbidity
14
2023
1665
0.470
Why?
Aortic Valve Stenosis
2
2021
255
0.470
Why?
Acute Disease
9
2024
1038
0.460
Why?
Decision Support Systems, Clinical
3
2025
279
0.460
Why?
Digoxin
1
2015
27
0.450
Why?
Colorado
14
2025
4595
0.450
Why?
Cost-Benefit Analysis
6
2026
640
0.440
Why?
Prospective Studies
20
2022
8123
0.440
Why?
Appointments and Schedules
1
2016
97
0.440
Why?
Clinical Trials as Topic
6
2019
1064
0.430
Why?
Periodicals as Topic
1
2017
214
0.430
Why?
Natriuretic Peptide, Brain
5
2022
110
0.430
Why?
Multimedia
1
2014
13
0.430
Why?
Heart Rate
4
2020
846
0.430
Why?
Proportional Hazards Models
14
2019
1331
0.420
Why?
Cardiac Rehabilitation
2
2026
48
0.420
Why?
Frail Elderly
2
2013
141
0.420
Why?
Neprilysin
4
2024
47
0.410
Why?
Drug Prescriptions
2
2018
314
0.410
Why?
Activities of Daily Living
2
2016
442
0.400
Why?
Cohort Studies
16
2023
6077
0.400
Why?
Hip Prosthesis
1
2014
43
0.400
Why?
Skilled Nursing Facilities
2
2016
152
0.400
Why?
Fluid Therapy
1
2015
154
0.390
Why?
Population Surveillance
1
2017
481
0.390
Why?
Severity of Illness Index
8
2018
2921
0.390
Why?
Shock, Cardiogenic
1
2014
65
0.390
Why?
Marijuana Abuse
1
2016
217
0.390
Why?
Chest Pain
2
2024
100
0.390
Why?
Socioeconomic Factors
6
2022
1327
0.380
Why?
Health Personnel
2
2022
754
0.380
Why?
Hyperkalemia
1
2013
35
0.380
Why?
Tetrazoles
6
2023
50
0.380
Why?
Prosthesis Failure
1
2014
126
0.380
Why?
Preoperative Period
1
2013
157
0.380
Why?
Hand Strength
1
2014
149
0.380
Why?
Hospital Mortality
8
2023
1051
0.380
Why?
Self Care
5
2025
396
0.370
Why?
Life Expectancy
2
2016
72
0.370
Why?
Electrocardiography
5
2023
667
0.370
Why?
Aortic Valve
2
2021
360
0.360
Why?
Drug Combinations
7
2022
400
0.360
Why?
Models, Statistical
2
2014
669
0.360
Why?
Furosemide
2
2023
37
0.360
Why?
Patient Admission
3
2015
216
0.360
Why?
Arrhythmias, Cardiac
4
2022
358
0.350
Why?
Hemodynamics
6
2023
1114
0.350
Why?
Algorithms
4
2022
1849
0.350
Why?
Cardiac Catheterization
3
2020
571
0.350
Why?
Chronic Disease
10
2022
1827
0.340
Why?
Sex Factors
9
2024
2107
0.340
Why?
Coronary Artery Bypass
2
2011
269
0.340
Why?
Comparative Effectiveness Research
1
2012
171
0.340
Why?
Social Environment
1
2013
246
0.340
Why?
Cross-Sectional Studies
11
2024
5899
0.330
Why?
Spouses
2
2025
107
0.330
Why?
Eligibility Determination
3
2024
73
0.330
Why?
Academic Medical Centers
3
2020
561
0.320
Why?
Emotions
7
2023
559
0.320
Why?
Health Literacy
4
2022
183
0.320
Why?
Communication
6
2025
980
0.320
Why?
Income
3
2020
206
0.320
Why?
Age Factors
12
2020
3347
0.310
Why?
Research Report
5
2022
89
0.310
Why?
Platelet Aggregation Inhibitors
5
2024
499
0.310
Why?
Patient Protection and Affordable Care Act
3
2017
105
0.310
Why?
Risk
4
2019
920
0.310
Why?
Substance Abuse Detection
2
2025
110
0.310
Why?
Erythrocyte Indices
1
2009
33
0.310
Why?
Adaptation, Psychological
7
2023
721
0.300
Why?
Sleep Apnea, Obstructive
3
2020
300
0.300
Why?
Cardiologists
3
2018
45
0.300
Why?
Drug Monitoring
3
2026
399
0.290
Why?
Poverty
1
2013
530
0.290
Why?
Drug Therapy, Combination
3
2024
1036
0.290
Why?
Weights and Measures
1
2008
7
0.280
Why?
Liver Function Tests
1
2009
103
0.280
Why?
Pain
2
2018
790
0.280
Why?
Evidence-Based Medicine
5
2025
731
0.280
Why?
Prealbumin
2
2025
37
0.270
Why?
Delivery of Health Care, Integrated
3
2021
305
0.270
Why?
Anemia
1
2009
190
0.270
Why?
Renal Insufficiency, Chronic
4
2021
640
0.270
Why?
Consensus
5
2022
467
0.270
Why?
Administration, Oral
9
2021
872
0.260
Why?
Patient Satisfaction
5
2024
706
0.260
Why?
Factor Xa Inhibitors
2
2020
195
0.260
Why?
Multivariate Analysis
7
2013
1543
0.260
Why?
Internationality
1
2008
156
0.260
Why?
Research Design
5
2023
1143
0.260
Why?
Mitral Valve Insufficiency
1
2008
69
0.260
Why?
Surgical Wound Infection
1
2011
349
0.260
Why?
Mitral Valve
1
2008
96
0.260
Why?
Pilot Projects
7
2026
1888
0.250
Why?
Betacoronavirus
2
2020
288
0.250
Why?
Cardiac Resynchronization Therapy
2
2022
63
0.250
Why?
Models, Cardiovascular
1
2008
194
0.250
Why?
Mobile Applications
3
2026
196
0.250
Why?
Reminder Systems
2
2025
149
0.240
Why?
Incidence
10
2018
2936
0.240
Why?
Hospitals, Community
2
2020
68
0.240
Why?
Congresses as Topic
4
2025
226
0.240
Why?
Troponin
2
2024
50
0.240
Why?
Erythrocytes
2
2009
750
0.240
Why?
Counselors
1
2026
10
0.240
Why?
Choice Behavior
2
2020
179
0.230
Why?
Sodium
2
2024
196
0.230
Why?
Patient Care
2
2023
120
0.230
Why?
Prosthesis Design
4
2018
358
0.230
Why?
Genetic Counseling
1
2026
82
0.230
Why?
Acute Kidney Injury
1
2013
866
0.230
Why?
Prosthesis Implantation
2
2019
156
0.220
Why?
Fatigue
4
2018
363
0.220
Why?
Cognitive Dysfunction
2
2024
481
0.220
Why?
Breast Neoplasms
3
2023
2418
0.220
Why?
Heart Valve Diseases
1
2026
151
0.220
Why?
Referral and Consultation
5
2023
881
0.220
Why?
Marijuana Smoking
2
2020
249
0.220
Why?
Cardiovascular Abnormalities
1
2025
14
0.220
Why?
Patient Compliance
4
2019
589
0.210
Why?
Frailty
2
2019
208
0.210
Why?
Neoplasms
4
2023
2954
0.210
Why?
Electric Countershock
3
2020
126
0.210
Why?
Kaplan-Meier Estimate
5
2018
970
0.210
Why?
Prevalence
9
2020
2861
0.210
Why?
Digital Divide
1
2024
3
0.200
Why?
Mortality
4
2020
375
0.200
Why?
Mass Screening
2
2010
1307
0.200
Why?
Checklist
1
2024
105
0.200
Why?
Creatinine
3
2023
511
0.200
Why?
Exercise
2
2026
2213
0.200
Why?
Infusions, Intravenous
3
2018
432
0.200
Why?
Probability
3
2016
309
0.190
Why?
Clinical Coding
2
2014
28
0.190
Why?
Health Services Needs and Demand
1
2025
287
0.190
Why?
Isosorbide Dinitrate
1
2023
3
0.190
Why?
Hydralazine
1
2023
6
0.190
Why?
Sports Medicine
1
2025
120
0.190
Why?
Primary Prevention
1
2025
222
0.190
Why?
Urea
1
2023
84
0.190
Why?
Genetic Testing
1
2026
492
0.190
Why?
Denmark
1
2023
51
0.190
Why?
Drug Utilization
2
2015
171
0.190
Why?
Perinatal Care
1
2023
61
0.190
Why?
Reproducibility of Results
5
2023
3416
0.180
Why?
Medical Marijuana
2
2024
120
0.180
Why?
Self-Management
1
2025
207
0.180
Why?
Cognition
5
2024
1292
0.180
Why?
Multicenter Studies as Topic
2
2024
417
0.180
Why?
Death
1
2023
129
0.180
Why?
Depression
4
2020
1575
0.180
Why?
Sports
1
2025
217
0.180
Why?
Pulmonary Artery
1
2008
1116
0.180
Why?
Recovery of Function
4
2020
725
0.180
Why?
Substance-Related Disorders
2
2025
1100
0.170
Why?
Atrial Appendage
1
2022
36
0.170
Why?
Patient Care Bundles
1
2021
30
0.170
Why?
Pandemics
2
2020
1707
0.170
Why?
Glucose
2
2024
1053
0.170
Why?
Electrophysiologic Techniques, Cardiac
1
2021
82
0.170
Why?
Advisory Committees
2
2021
228
0.170
Why?
Universities
1
2023
451
0.170
Why?
Health Services Accessibility
2
2025
1107
0.170
Why?
Athletes
1
2025
432
0.160
Why?
Insurance, Health, Reimbursement
1
2021
97
0.160
Why?
Myocardial Contraction
2
2019
292
0.160
Why?
Age Distribution
3
2012
399
0.160
Why?
Relaxin
1
2020
18
0.160
Why?
Norway
1
2020
41
0.160
Why?
Georgia
1
2020
79
0.160
Why?
Hypertension
3
2021
1272
0.160
Why?
Health Systems Plans
1
2020
3
0.160
Why?
Trust
1
2022
160
0.160
Why?
Health Services Misuse
1
2020
33
0.160
Why?
Psychology
1
2021
85
0.160
Why?
Anxiety
3
2018
1125
0.160
Why?
Social Determinants of Health
2
2024
317
0.160
Why?
Financing, Government
1
2020
53
0.160
Why?
Palliative Medicine
2
2018
24
0.150
Why?
Diagnosis-Related Groups
2
2021
34
0.150
Why?
Health Resources
2
2012
131
0.150
Why?
Odds Ratio
5
2014
1077
0.150
Why?
Self Report
1
2024
870
0.150
Why?
Thoracentesis
1
2019
6
0.150
Why?
Home Care Services
2
2020
293
0.150
Why?
National Institutes of Health (U.S.)
1
2020
147
0.150
Why?
Pharmaceutical Preparations
1
2021
172
0.150
Why?
Mandatory Programs
1
2019
16
0.150
Why?
Nurses
3
2018
171
0.150
Why?
Pyridones
1
2021
210
0.150
Why?
Minimal Clinically Important Difference
1
2019
35
0.140
Why?
Mental Competency
1
2019
28
0.140
Why?
Tertiary Care Centers
1
2020
196
0.140
Why?
Dyspnea
3
2018
251
0.140
Why?
Home Infusion Therapy
1
2018
4
0.140
Why?
Atherosclerosis
1
2022
410
0.140
Why?
Guidelines as Topic
2
2017
267
0.140
Why?
Fee-for-Service Plans
2
2018
98
0.140
Why?
Contraindications
2
2015
88
0.140
Why?
Ventricular Function
1
2018
53
0.140
Why?
Coronary Artery Disease
3
2019
751
0.140
Why?
Heart Failure, Diastolic
1
2018
23
0.130
Why?
Cooperative Behavior
2
2024
471
0.130
Why?
Reimbursement Mechanisms
1
2018
79
0.130
Why?
Drug Administration Schedule
3
2020
790
0.130
Why?
Thromboembolism
2
2021
129
0.130
Why?
Cost Savings
2
2021
87
0.130
Why?
Heart Conduction System
1
2018
96
0.130
Why?
Dose-Response Relationship, Drug
2
2014
2022
0.130
Why?
Patient Safety
3
2021
352
0.130
Why?
Extracorporeal Membrane Oxygenation
1
2022
370
0.130
Why?
Quality Control
1
2017
163
0.130
Why?
Medical Records
1
2018
193
0.130
Why?
Machine Learning
1
2023
594
0.130
Why?
Spiritual Therapies
1
2017
13
0.130
Why?
Vaccines
1
2022
389
0.130
Why?
Glomerular Filtration Rate
3
2026
745
0.120
Why?
Caliciviridae Infections
1
2016
18
0.120
Why?
Thrombosis
1
2021
398
0.120
Why?
Attitude of Health Personnel
3
2020
1219
0.120
Why?
Nervous System Diseases
1
2020
288
0.120
Why?
Blood Coagulation
1
2018
267
0.120
Why?
Mexiletine
1
2016
6
0.120
Why?
Amphetamine
1
2016
37
0.120
Why?
Mental Health
1
2023
779
0.120
Why?
Defibrillators
1
2016
23
0.120
Why?
Thrombolytic Therapy
1
2017
165
0.110
Why?
Truth Disclosure
1
2016
51
0.110
Why?
Predictive Value of Tests
4
2021
2113
0.110
Why?
Social Security
1
2015
5
0.110
Why?
Medical Indigency
1
2015
11
0.110
Why?
Uncertainty
1
2016
145
0.110
Why?
Pain Management
2
2016
421
0.110
Why?
Psychotherapy
1
2017
183
0.110
Why?
Databases, Factual
2
2012
1493
0.110
Why?
Bereavement
1
2016
71
0.110
Why?
Young Adult
9
2019
14330
0.110
Why?
Public Health
1
2020
574
0.110
Why?
Antihypertensive Agents
2
2023
519
0.110
Why?
Transplant Recipients
1
2016
177
0.110
Why?
Waiting Lists
1
2017
251
0.110
Why?
Information Seeking Behavior
1
2015
39
0.110
Why?
Glycogen Storage Disease Type IIb
1
2014
27
0.110
Why?
Assisted Circulation
1
2014
26
0.100
Why?
Polypharmacy
1
2015
94
0.100
Why?
Patient Outcome Assessment
1
2015
129
0.100
Why?
Emergency Service, Hospital
2
2023
2363
0.100
Why?
Social Support
4
2025
646
0.100
Why?
Drug Hypersensitivity
1
2015
93
0.100
Why?
Health Surveys
3
2023
511
0.100
Why?
Continuous Positive Airway Pressure
1
2015
91
0.100
Why?
Kidney
2
2020
1498
0.100
Why?
Echocardiography
2
2014
645
0.100
Why?
Cobalt
1
2014
50
0.100
Why?
Return to Sport
2
2026
118
0.100
Why?
Infant, Low Birth Weight
1
2014
154
0.100
Why?
Potassium
1
2013
151
0.100
Why?
Calcium
1
2019
1181
0.090
Why?
Data Collection
1
2016
650
0.090
Why?
Digestive System Diseases
1
2013
28
0.090
Why?
Women's Health
1
2015
317
0.090
Why?
Anthracyclines
1
2012
49
0.090
Why?
Peripheral Arterial Disease
1
2019
507
0.090
Why?
Health Maintenance Organizations
1
2012
106
0.090
Why?
Drug Utilization Review
1
2012
60
0.090
Why?
Critical Care
1
2018
706
0.090
Why?
Antineoplastic Agents
2
2014
2219
0.090
Why?
Monitoring, Physiologic
1
2013
279
0.090
Why?
Patients
2
2024
183
0.090
Why?
Geriatric Assessment
1
2013
244
0.090
Why?
Acculturation
1
2012
55
0.090
Why?
Sickness Impact Profile
1
2011
67
0.090
Why?
Infant, Newborn
1
2023
6460
0.080
Why?
Running
1
2014
235
0.080
Why?
Echocardiography, Three-Dimensional
1
2012
71
0.080
Why?
Tachycardia
1
2011
58
0.080
Why?
Culture
1
2012
122
0.080
Why?
Hyponatremia
1
2011
42
0.080
Why?
Diabetes Mellitus
1
2019
1101
0.080
Why?
Myocardial Ischemia
1
2012
286
0.080
Why?
Birth Weight
1
2014
521
0.080
Why?
Body Mass Index
2
2019
2458
0.080
Why?
Cognition Disorders
1
2015
559
0.080
Why?
Lung Diseases
1
2017
787
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
928
0.080
Why?
Motivation
1
2015
605
0.080
Why?
Logistic Models
2
2013
2126
0.080
Why?
Health Services Research
1
2013
390
0.080
Why?
Antidiuretic Hormone Receptor Antagonists
1
2010
10
0.080
Why?
Pregnancy
1
2023
7230
0.080
Why?
Heart
1
2014
626
0.080
Why?
Confidence Intervals
3
2020
329
0.080
Why?
Benzazepines
1
2010
36
0.080
Why?
Injections, Intravenous
1
2010
197
0.080
Why?
Erythropoiesis
1
2009
57
0.080
Why?
Minority Groups
1
2012
286
0.070
Why?
Electric Stimulation Therapy
1
2010
63
0.070
Why?
Diagnosis, Differential
1
2014
1503
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2013
449
0.070
Why?
Endpoint Determination
1
2009
84
0.070
Why?
Aspartate Aminotransferases
1
2009
86
0.070
Why?
Actuarial Analysis
1
2008
15
0.070
Why?
Bilirubin
1
2009
101
0.070
Why?
Alberta
1
2008
25
0.070
Why?
Focus Groups
2
2023
588
0.070
Why?
Data Interpretation, Statistical
1
2010
368
0.070
Why?
Alanine Transaminase
1
2009
151
0.070
Why?
United States Food and Drug Administration
1
2009
208
0.070
Why?
Alkaline Phosphatase
1
2009
144
0.070
Why?
Syndrome
1
2009
380
0.070
Why?
ROC Curve
1
2010
617
0.070
Why?
Serum Albumin
1
2009
147
0.070
Why?
Residence Characteristics
1
2011
385
0.070
Why?
DNA
1
2014
1421
0.070
Why?
Lung Neoplasms
2
2023
2675
0.060
Why?
Insurance Coverage
2
2021
248
0.060
Why?
Ultrafiltration
1
2007
28
0.060
Why?
Heart Function Tests
1
2007
59
0.060
Why?
Pericarditis
1
2026
12
0.060
Why?
Social Workers
2
2018
55
0.060
Why?
Tanzania
1
2026
76
0.060
Why?
Exercise Test
2
2023
637
0.060
Why?
Child
2
2023
22693
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2012
992
0.060
Why?
Benzimidazoles
1
2007
191
0.060
Why?
Taiwan
1
2025
48
0.060
Why?
Precision Medicine
2
2024
462
0.060
Why?
Mucocutaneous Lymph Node Syndrome
1
2026
96
0.060
Why?
Nebraska
1
2025
21
0.060
Why?
Wyoming
1
2025
27
0.060
Why?
Liver Diseases
1
2009
304
0.060
Why?
Cluster Analysis
2
2018
496
0.060
Why?
Vasodilator Agents
1
2007
326
0.050
Why?
Delayed Diagnosis
1
2025
102
0.050
Why?
Review Literature as Topic
1
2025
53
0.050
Why?
Lung
1
2018
4122
0.050
Why?
Genomics
1
2010
853
0.050
Why?
Diabetes Complications
1
2006
219
0.050
Why?
Troponin T
1
2024
63
0.050
Why?
Benzodiazepines
1
2025
158
0.050
Why?
Natriuretic Peptides
1
2023
9
0.050
Why?
Troponin I
1
2024
74
0.050
Why?
Feasibility Studies
2
2020
1135
0.050
Why?
Combined Modality Therapy
1
2007
1271
0.050
Why?
Group Processes
1
2024
62
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2024
135
0.050
Why?
Mental Disorders
1
2013
1148
0.050
Why?
Prescriptions
1
2023
77
0.050
Why?
Proteomics
1
2010
1203
0.050
Why?
Cardiac Output
1
2023
176
0.050
Why?
Renin-Angiotensin System
1
2023
80
0.050
Why?
Heterocyclic Compounds, 2-Ring
1
2023
18
0.050
Why?
Cannabinoids
1
2025
182
0.050
Why?
Heuristics
1
2022
11
0.050
Why?
Information Systems
1
2023
58
0.050
Why?
Empiricism
1
2022
2
0.050
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2022
17
0.050
Why?
Sexism
1
2023
70
0.040
Why?
Respiratory Tract Infections
1
2026
403
0.040
Why?
Genetic Predisposition to Disease
2
2025
2488
0.040
Why?
Critical Illness
1
2008
908
0.040
Why?
Multimorbidity
1
2022
65
0.040
Why?
Massachusetts
1
2022
178
0.040
Why?
Cardiac Surgical Procedures
1
2008
611
0.040
Why?
Interprofessional Relations
1
2024
275
0.040
Why?
Program Development
1
2023
371
0.040
Why?
Phenotype
2
2021
3206
0.040
Why?
Policy
1
2022
147
0.040
Why?
Magnetic Resonance Imaging
1
2014
3926
0.040
Why?
Critical Pathways
1
2022
104
0.040
Why?
Urban Health Services
1
2020
68
0.040
Why?
Attitude
1
2022
253
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2023
344
0.040
Why?
International Classification of Diseases
1
2021
142
0.040
Why?
Organizations, Nonprofit
1
2020
17
0.040
Why?
Private Sector
1
2020
50
0.040
Why?
Intracranial Embolism
1
2019
34
0.040
Why?
Public Opinion
1
2020
61
0.040
Why?
Stakeholder Participation
1
2020
90
0.040
Why?
Embolism
1
2019
49
0.040
Why?
Contraindications, Procedure
1
2019
14
0.040
Why?
Visual Analog Scale
1
2019
33
0.040
Why?
Disease Susceptibility
1
2021
339
0.040
Why?
Pyrimidines
1
2023
532
0.040
Why?
Canada
1
2020
432
0.040
Why?
Rural Health Services
1
2020
139
0.040
Why?
Myocardial Revascularization
1
2019
85
0.040
Why?
Peripheral Vascular Diseases
1
2019
102
0.040
Why?
Hyperlipidemias
1
2019
120
0.040
Why?
Observational Studies as Topic
1
2019
133
0.030
Why?
Government Regulation
1
2018
38
0.030
Why?
Quality-Adjusted Life Years
1
2019
122
0.030
Why?
Survival
1
2018
38
0.030
Why?
Peripheral Nervous System Diseases
1
2019
135
0.030
Why?
Treatment Failure
1
2019
361
0.030
Why?
Policy Making
1
2018
83
0.030
Why?
Artificial Intelligence
1
2023
389
0.030
Why?
Peptide Fragments
1
2022
693
0.030
Why?
Drug Dosage Calculations
1
2018
27
0.030
Why?
Medicare Part D
1
2018
23
0.030
Why?
Walk Test
1
2018
82
0.030
Why?
Patient Health Questionnaire
1
2018
43
0.030
Why?
Hospitals, Rural
1
2018
49
0.030
Why?
Sensitivity and Specificity
2
2017
1998
0.030
Why?
Sex Characteristics
1
2023
801
0.030
Why?
Hospitals, Urban
1
2018
140
0.030
Why?
Risk Management
1
2018
81
0.030
Why?
Random Allocation
1
2018
366
0.030
Why?
Risk Reduction Behavior
1
2019
220
0.030
Why?
Recombinant Proteins
1
2020
1361
0.030
Why?
Single-Blind Method
1
2018
313
0.030
Why?
Exercise Tolerance
1
2019
289
0.030
Why?
Diphenoxylate
1
2016
5
0.030
Why?
Antidiarrheals
1
2016
12
0.030
Why?
Loperamide
1
2016
12
0.030
Why?
Electronic Health Records
1
2025
1210
0.030
Why?
Atropine
1
2016
37
0.030
Why?
Emotional Adjustment
1
2016
18
0.030
Why?
Karnofsky Performance Status
1
2016
37
0.030
Why?
Voltage-Gated Sodium Channel Blockers
1
2016
7
0.030
Why?
Chromatography, Gas
1
2016
31
0.030
Why?
Prostatic Neoplasms
1
2023
972
0.030
Why?
Catheterization, Swan-Ganz
1
2016
9
0.030
Why?
Gastrointestinal Agents
1
2016
63
0.030
Why?
Longitudinal Studies
2
2016
3017
0.030
Why?
Postoperative Period
1
2017
355
0.030
Why?
Medically Uninsured
1
2017
134
0.030
Why?
Propensity Score
1
2018
376
0.030
Why?
Data Accuracy
1
2016
64
0.030
Why?
Physicians, Primary Care
1
2018
210
0.030
Why?
Symptom Assessment
1
2016
138
0.030
Why?
Colorectal Neoplasms
1
2023
874
0.030
Why?
Life Change Events
1
2016
144
0.030
Why?
Video Recording
1
2016
219
0.030
Why?
Lysosomal-Associated Membrane Protein 2
1
2014
32
0.030
Why?
Primary Health Care
1
2025
1776
0.030
Why?
Reference Values
1
2016
796
0.030
Why?
Linear Models
1
2017
857
0.030
Why?
Treatment Refusal
1
2015
99
0.030
Why?
Family Relations
1
2015
87
0.030
Why?
Central Nervous System Stimulants
1
2016
183
0.030
Why?
Diastole
1
2014
147
0.020
Why?
Polymerase Chain Reaction
1
2016
1031
0.020
Why?
Morbidity
1
2014
319
0.020
Why?
DNA Mutational Analysis
1
2014
410
0.020
Why?
Hospitals, Veterans
1
2014
256
0.020
Why?
History, Ancient
1
2013
54
0.020
Why?
Proteinuria
1
2013
103
0.020
Why?
Systole
1
2013
179
0.020
Why?
Imaging, Three-Dimensional
1
2016
582
0.020
Why?
Chi-Square Distribution
1
2013
517
0.020
Why?
Immunosuppressive Agents
1
2016
829
0.020
Why?
Trastuzumab
1
2012
119
0.020
Why?
Intensive Care Units
1
2018
925
0.020
Why?
Antibiotics, Antineoplastic
1
2012
141
0.020
Why?
Forecasting
1
2013
388
0.020
Why?
History, 21st Century
1
2012
224
0.020
Why?
Chemotherapy, Adjuvant
1
2012
429
0.020
Why?
Medical Audit
1
2011
78
0.020
Why?
Evidence-Based Practice
1
2013
231
0.020
Why?
History, 20th Century
1
2012
330
0.020
Why?
Managed Care Programs
1
2011
137
0.020
Why?
Hypoglycemic Agents
1
2019
1412
0.020
Why?
Social Class
1
2011
260
0.020
Why?
Needs Assessment
1
2011
404
0.020
Why?
Students
1
2014
649
0.020
Why?
Health Care Rationing
1
2008
54
0.020
Why?
Hypertension, Pulmonary
1
2019
1957
0.020
Why?
Databases as Topic
1
2007
70
0.020
Why?
Case-Control Studies
1
2014
3647
0.010
Why?
Adolescent
2
2017
22557
0.010
Why?
Tomography, X-Ray Computed
1
2016
2786
0.010
Why?
Mutation
1
2014
4093
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1998
0.010
Why?
Animals
1
2012
38107
0.000
Why?
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)